Aclacinomycin A

Therapeutic Indications

Aclarubicin is indicated for:

at least one of
Acute lymphoblastic leukaemia

Acute myeloid leukaemia

Acute promyelocytic leukaemia

Acute monocytic leukaemia

Acute megakaryoblastic leukaemia

Acute leukaemia of unspecified cell type

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous


Active ingredient Aclarubicin is contraindicated in the following cases:

No gender/age discrimination

at least one of
Chronic rheumatic heart diseases

Ischaemic heart diseases

Other forms of heart disease